VERI Veritone | $1.50
+5.7% | 7/3/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.00 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 7/3/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 7/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | Low | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 7/1/2025 |
CLNN Clene | $3.94
-0.4% | 6/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 6/30/2025 |
CRMD CorMedix | $11.64
+0.4% | 6/30/2025 | Downgraded by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 6/30/2025 |
CTXR Citius Pharmaceuticals | $2.20
+4.5% | 6/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $6.00 | Medium | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 6/30/2025 |
OSTX OS Therapies | $1.87
-2.1% | 6/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 6/30/2025 |
OMER Omeros | $3.20
+3.6% | 6/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 6/30/2025 |
RVPH Reviva Pharmaceuticals | $0.37
-4.4% | 6/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 6/27/2025 |
IVVD Invivyd | $0.75
+4.1% | 6/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 6/26/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 6/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 | Low | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 6/26/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
PSTV Plus Therapeutics | $0.30
-3.6% | 6/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Hold | $9.00 | Low | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 6/25/2025 |
IMUX Immunic | $0.73
+2.2% | 6/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Low | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 6/25/2025 |
CTSO Cytosorbents | $1.04
+4.0% | 6/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 6/25/2025 |
OSTX OS Therapies | $1.87
-2.1% | 6/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 6/24/2025 |
BMEA Biomea Fusion | $1.65
+0.2% | 6/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 6/24/2025 |
CRMD CorMedix | $11.64
+0.4% | 6/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 6/23/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 6/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 6/23/2025 |
LCTX Lineage Cell Therapeutics | $1.01
-1.0% | 6/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 6/23/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 6/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 | Low | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 6/20/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 6/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Low | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 6/18/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 6/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 6/17/2025 |
BMEA Biomea Fusion | $1.65
+0.2% | 6/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 6/13/2025 |
QNCX Quince Therapeutics | $1.61
+0.3% | 6/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 6/13/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 6/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 6/12/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 6/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 6/12/2025 |
ADUR Aduro Clean Technologies | $9.03
+0.8% | 6/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $50.00 -> $48.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 6/11/2025 |
CRVO CervoMed | $5.72
+2.9% | 6/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 6/11/2025 |
ANIX Anixa Biosciences | $3.35
+5.0% | 6/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 6/10/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 6/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 6/10/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 6/9/2025 |
HUMA Humacyte | $2.27
-1.9% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 6/9/2025 |
CTXR Citius Pharmaceuticals | $2.20
+4.5% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 6/9/2025 |
OSTX OS Therapies | $1.87
-2.1% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 6/9/2025 |
RCEL Avita Medical | $5.52
+6.7% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $19.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 6/6/2025 |
NNOX Nano-X Imaging | $5.28
-1.0% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 6/6/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 6/6/2025 |
IMUX Immunic | $0.73
+2.2% | 6/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 6/5/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 6/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 6/4/2025 |
QNCX Quince Therapeutics | $1.61
+0.3% | 6/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.00 | Medium | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 6/4/2025 |
RVPH Reviva Pharmaceuticals | $0.37
-4.4% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 | Low | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 6/3/2025 |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
IBRX ImmunityBio | $2.70
+2.3% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 6/3/2025 |
MSAI MultiSensor AI | $0.66
+3.4% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 6/3/2025 |
TRVI Trevi Therapeutics | $5.90
-1.4% | 6/2/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 6/2/2025 |
IMUX Immunic | $0.73
+2.2% | 5/29/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $10.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 5/29/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/29/2025 |
ESLA Estrella Immunopharma | $0.92
+4.9% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 5/29/2025 |
ANIX Anixa Biosciences | $3.35
+5.0% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 5/29/2025 |
CLGN CollPlant Biotechnologies | $1.38
-2.5% | 5/28/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $12.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 5/28/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 5/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 5/28/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 5/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 5/27/2025 |
NNOX Nano-X Imaging | $5.28
-1.0% | 5/23/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $10.00 | Low | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 5/23/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 5/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 -> $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/22/2025 |
MVIS Microvision | $1.13
+1.8% | 5/21/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 -> $2.50 | Medium | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 5/21/2025 |
RVPH Reviva Pharmaceuticals | $0.37
-4.4% | 5/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $8.00 -> $3.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 5/20/2025 |
PED PEDEVCO | $0.64
-0.1% | 5/20/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 5/20/2025 |
IMNN Imunon | $0.79
-1.1% | 5/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Low | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/19/2025 |
IVVD Invivyd | $0.75
+4.1% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 5/16/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Low | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 5/16/2025 |
HOVR New Horizon Aircraft | $1.57
-4.6% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 5/16/2025 |
CTXR Citius Pharmaceuticals | $2.20
+4.5% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 5/15/2025 |
BMEA Biomea Fusion | $1.65
+0.2% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 5/15/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 5/15/2025 |
CTSO Cytosorbents | $1.04
+4.0% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 5/15/2025 |
OSTX OS Therapies | $1.87
-2.1% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 5/15/2025 |
HUMA Humacyte | $2.27
-1.9% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 5/13/2025 |
IMNN Imunon | $0.79
-1.1% | 5/13/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $17.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/13/2025 |
CRVO CervoMed | $5.72
+2.9% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 5/13/2025 |
NRSN NeuroSense Therapeutics | $1.91
+0.5% | 5/12/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $14.00 | High | View details for D. Boral Capital rating of NeuroSense Therapeutics (NASDAQ:NRSN) on 5/12/2025 |
MVIS Microvision | $1.13
+1.8% | 5/13/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $2.50 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 5/13/2025 |
USEG U.S. Energy | $1.38
+0.4% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 5/13/2025 |
OMER Omeros | $3.20
+3.6% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 5/13/2025 |
NOTE FiscalNote | $0.75
+5.7% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 5/13/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 5/12/2025 |
UAMY United States Antimony | $2.22
+4.0% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of United States Antimony (NYSE:UAMY) on 5/12/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 5/12/2025 | Target Raised by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/12/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 5/12/2025 |
CLNN Clene | $3.94
-0.4% | 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 5/8/2025 |
CNTX Context Therapeutics | $0.66
+3.7% | 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 5/8/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 5/8/2025 |
CXDO Crexendo | $6.31
-2.4% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 5/7/2025 |
IMNN Imunon | $0.79
-1.1% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/7/2025 |
OMER Omeros | $3.20
+3.6% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Low | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 5/7/2025 |
CRMD CorMedix | $11.64
+0.4% | 5/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 5/6/2025 |
BMEA Biomea Fusion | $1.65
+0.2% | 5/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 5/6/2025 |
PSTV Plus Therapeutics | $0.30
-3.6% | 5/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Medium | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 5/5/2025 |
CTSO Cytosorbents | $1.04
+4.0% | 5/2/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 5/2/2025 |
TTI Tetra Technologies | $3.40
| 5/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $4.00 | High | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 5/1/2025 |
LUNG Pulmonx | $2.78
+2.0% | 5/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 5/1/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/30/2025 |
IMUX Immunic | $0.73
+2.2% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/30/2025 |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
VNRX VolitionRx | $0.79
+5.1% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 4/30/2025 |
GFAI Guardforce AI | $1.19
+0.8% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | Low | View details for D. Boral Capital rating of Guardforce AI (NASDAQ:GFAI) on 4/28/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 4/29/2025 |
CNTX Context Therapeutics | $0.66
+3.7% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/29/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/28/2025 |
CMPX Compass Therapeutics | $2.78
+5.9% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | Medium | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/28/2025 |
VERI Veritone | $1.50
+5.7% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 4/28/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 4/28/2025 |
RVPH Reviva Pharmaceuticals | $0.37
-4.4% | 4/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/24/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 4/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/23/2025 |
UAMY United States Antimony | $2.22
+4.0% | 4/23/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $5.00 | Low | View details for D. Boral Capital rating of United States Antimony (NYSE:UAMY) on 4/23/2025 |
COYA Coya Therapeutics | $6.27
+8.4% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/22/2025 |
OSTX OS Therapies | $1.87
-2.1% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/22/2025 |
ENLV Enlivex Therapeutics | $1.18
+4.0% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/21/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/21/2025 |
CMPX Compass Therapeutics | $2.78
+5.9% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/21/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 4/21/2025 |
HOVR New Horizon Aircraft | $1.57
-4.6% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 4/21/2025 |
NNOX Nano-X Imaging | $5.28
-1.0% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 4/17/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 4/17/2025 |
ADUR Aduro Clean Technologies | $9.03
+0.8% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 4/17/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 4/15/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/15/2025 |
MDCX Medicus Pharma | $3.38
+5.0% | 4/14/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/14/2025 |
SCLX Scilex | $6.00
-3.8% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/11/2025 |
OMER Omeros | $3.20
+3.6% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/11/2025 |
ANIX Anixa Biosciences | $3.35
+5.0% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 4/10/2025 |
IMUX Immunic | $0.73
+2.2% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/10/2025 |
RCEL Avita Medical | $5.52
+6.7% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 4/10/2025 |
CNTX Context Therapeutics | $0.66
+3.7% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/9/2025 |
MNOV MediciNova | $1.26
-0.8% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 4/9/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/9/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/9/2025 |
CRMD CorMedix | $11.64
+0.4% | 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 4/8/2025 |
CLNN Clene | $3.94
-0.4% | 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 4/8/2025 |
OSTX OS Therapies | $1.87
-2.1% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/7/2025 |
AVXL Anavex Life Sciences | $10.72
+1.4% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 4/7/2025 |
RCEL Avita Medical | $5.52
+6.7% | 4/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 4/4/2025 |
ENLV Enlivex Therapeutics | $1.18
+4.0% | 4/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/3/2025 |
SCLX Scilex | $6.00
-3.8% | 4/2/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $630.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/2/2025 |
PED PEDEVCO | $0.64
-0.1% | 4/2/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | High | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 4/2/2025 |
MSAI MultiSensor AI | $0.66
+3.4% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 -> $2.50 | Medium | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 4/1/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/1/2025 |
CTSO Cytosorbents | $1.04
+4.0% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 4/1/2025 |
CARM Carisma Therapeutics | $0.41
-3.3% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $1.00 | High | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 4/1/2025 |
RVPH Reviva Pharmaceuticals | $0.37
-4.4% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $8.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/1/2025 |
IMUX Immunic | $0.73
+2.2% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/1/2025 |
CMPX Compass Therapeutics | $2.78
+5.9% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/1/2025 |
OMER Omeros | $3.20
+3.6% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/1/2025 |
NNOX Nano-X Imaging | $5.28
-1.0% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 3/31/2025 |
Trump’s New Order Could Boost Social Security Benefits by 400% (Ad) If you collect—or plan to collect—Social Security, you need to see this.
A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse...
...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier. Click here to watch the full presentation before it's too late. |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/31/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/31/2025 |
OSTX OS Therapies | $1.87
-2.1% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 3/31/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/31/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/31/2025 |
CKPT Checkpoint Therapeutics | $4.26
| 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.80 -> $4.80 | Low | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/31/2025 |
VNRX VolitionRx | $0.79
+5.1% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/31/2025 |
PSTV Plus Therapeutics | $0.30
-3.6% | 3/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 3/28/2025 |
CLGN CollPlant Biotechnologies | $1.38
-2.5% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | Low | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 3/27/2025 |
EVTL Vertical Aerospace | $6.91
+4.1% | 3/27/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $15.00 | Medium | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/27/2025 |
COYA Coya Therapeutics | $6.27
+8.4% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/27/2025 |
HUMA Humacyte | $2.27
-1.9% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/26/2025 |
TTI Tetra Technologies | $3.40
| 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | High | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 3/26/2025 |
ANIX Anixa Biosciences | $3.35
+5.0% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/26/2025 |
CRVO CervoMed | $5.72
+2.9% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/26/2025 |
MVIS Microvision | $1.13
+1.8% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $3.00 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 3/25/2025 |
CRMD CorMedix | $11.64
+0.4% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/25/2025 |
QNCX Quince Therapeutics | $1.61
+0.3% | 3/25/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/24/2025 |
IMNN Imunon | $0.79
-1.1% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 3/24/2025 |
CLNN Clene | $3.94
-0.4% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
OMER Omeros | $3.20
+3.6% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 3/21/2025 |
CNTX Context Therapeutics | $0.66
+3.7% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
VNRX VolitionRx | $0.79
+5.1% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/20/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/20/2025 |
IVVD Invivyd | $0.75
+4.1% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/20/2025 |
TRVI Trevi Therapeutics | $5.90
-1.4% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
BMEA Biomea Fusion | $1.65
+0.2% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 3/19/2025 |
COYA Coya Therapeutics | $6.27
+8.4% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/18/2025 |
RCEL Avita Medical | $5.52
+6.7% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 3/18/2025 |
CRVO CervoMed | $5.72
+2.9% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/17/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2025 |
VERI Veritone | $1.50
+5.7% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
NOTE FiscalNote | $0.75
+5.7% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 3/17/2025 |
PSTV Plus Therapeutics | $0.30
-3.6% | 3/17/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 3/17/2025 |
MNOV MediciNova | $1.26
-0.8% | 3/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 3/14/2025 |
USEG U.S. Energy | $1.38
+0.4% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 3/13/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
PED PEDEVCO | $0.64
-0.1% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 3/13/2025 |
CLNN Clene | $3.94
-0.4% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
VNRX VolitionRx | $0.79
+5.1% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/12/2025 |
LCTX Lineage Cell Therapeutics | $1.01
-1.0% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 3/11/2025 |
CRVO CervoMed | $5.72
+2.9% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/11/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/10/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 3/10/2025 |
COYA Coya Therapeutics | $6.27
+8.4% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/10/2025 |
CKPT Checkpoint Therapeutics | $4.26
| 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $4.80 | High | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/10/2025 |
LUNG Pulmonx | $2.78
+2.0% | 3/10/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Low | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 3/10/2025 |
HUMA Humacyte | $2.27
-1.9% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/7/2025 |
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
TRVI Trevi Therapeutics | $5.90
-1.4% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/7/2025 |
CXDO Crexendo | $6.31
-2.4% | 3/6/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $7.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 3/6/2025 |
ADUR Aduro Clean Technologies | $9.03
+0.8% | 3/6/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 3/6/2025 |
CRMD CorMedix | $11.64
+0.4% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/5/2025 |
IVVD Invivyd | $0.75
+4.1% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/5/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/4/2025 |
VNRX VolitionRx | $0.79
+5.1% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/4/2025 |
TVGN Semper Paratus Acquisition | $1.25
-0.4% | 3/4/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 3/4/2025 |
ENLV Enlivex Therapeutics | $1.18
+4.0% | 3/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/3/2025 |
SCLX Scilex | $6.00
-3.8% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $770.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 2/28/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/28/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Low | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/27/2025 |
IMNN Imunon | $0.79
-1.1% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/27/2025 |
TTI Tetra Technologies | $3.40
| 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 2/27/2025 |
MSAI MultiSensor AI | $0.66
+3.4% | 2/26/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/26/2025 |
IMUX Immunic | $0.73
+2.2% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/26/2025 |
HUMA Humacyte | $2.27
-1.9% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/26/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/26/2025 |
NOTE FiscalNote | $0.75
+5.7% | 2/25/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.75 | Low | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 2/25/2025 |
NNOX Nano-X Imaging | $5.28
-1.0% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 2/25/2025 |
CMPX Compass Therapeutics | $2.78
+5.9% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 2/25/2025 |
CTSO Cytosorbents | $1.04
+4.0% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2025 |
CLNN Clene | $3.94
-0.4% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
TRVI Trevi Therapeutics | $5.90
-1.4% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 2/24/2025 |
IVVD Invivyd | $0.75
+4.1% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/24/2025 |
MNOV MediciNova | $1.26
-0.8% | 2/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 2/21/2025 |
OMER Omeros | $3.20
+3.6% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 2/20/2025 |
IMUX Immunic | $0.73
+2.2% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/20/2025 |
RCEL Avita Medical | $5.52
+6.7% | 2/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $22.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 2/20/2025 |
OSTX OS Therapies | $1.87
-2.1% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 2/20/2025 |
IMNN Imunon | $0.79
-1.1% | 2/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/19/2025 |
CRVO CervoMed | $5.72
+2.9% | 2/19/2025 | Upgraded by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/19/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/18/2025 |
MSAI MultiSensor AI | $0.66
+3.4% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | High | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/18/2025 |
CTXR Citius Pharmaceuticals | $2.20
+4.5% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/18/2025 |
ESLA Estrella Immunopharma | $0.92
+4.9% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/18/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 2/18/2025 |
IBRX ImmunityBio | $2.70
+2.3% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/14/2025 |
RCEL Avita Medical | $5.52
+6.7% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 2/14/2025 |
FBLG FibroBiologics | $0.64
+4.7% | 2/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
URGN Urogen Pharma | $13.49
+4.1% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 2/12/2025 |
CLGN CollPlant Biotechnologies | $1.38
-2.5% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/12/2025 |
KAPA Kairos Pharma | $0.65
-6.3% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/12/2025 |
AVXL Anavex Life Sciences | $10.72
+1.4% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/12/2025 |
LCTX Lineage Cell Therapeutics | $1.01
-1.0% | 2/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
HOTH Hoth Therapeutics | $1.21
+0.4% | 2/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 2/11/2025 |
ANVS Annovis Bio | $2.39
+0.2% | 2/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | High | View details for D. Boral Capital rating of Annovis Bio (NYSE:ANVS) on 2/10/2025 |
MVIS Microvision | $1.13
+1.8% | 2/10/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $3.00 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 2/10/2025 |
ENLV Enlivex Therapeutics | $1.18
+4.0% | 2/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 2/7/2025 |
VNRX VolitionRx | $0.79
+5.1% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 2/6/2025 |
COYA Coya Therapeutics | $6.27
+8.4% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
CLNN Clene | $3.94
-0.4% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/6/2025 |
QNCX Quince Therapeutics | $1.61
+0.3% | 2/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 2/5/2025 |
CLGN CollPlant Biotechnologies | $1.38
-2.5% | 2/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/4/2025 |
IVVD Invivyd | $0.75
+4.1% | 2/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/3/2025 |
VERI Veritone | $1.50
+5.7% | 2/3/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/3/2025 |
OSTX OS Therapies | $1.87
-2.1% | 1/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/30/2025 |
VNRX VolitionRx | $0.79
+5.1% | 1/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/29/2025 |
NRXP NRx Pharmaceuticals | $3.31
-0.3% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/28/2025 |
AVXL Anavex Life Sciences | $10.72
+1.4% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
